 
r. Chen is a co-founder of KAI Pharmaceuticals, a Skyline portfolio company, where he served in a number of positions, including Senior Director of Technology. He received a BA in Biochemistry from University of California at Berkeley in and a Ph.D. from the Department of Molecular Pharmacology at Stanford University. He received an MBA from Stanford Business School in 2009.

*Click on each team member for personal bio*
|
|